These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6283186)

  • 1. Newer pertussis vaccines on horizon.
    González ER
    JAMA; 1982 Jul; 248(1):22-3. PubMed ID: 6283186
    [No Abstract]   [Full Text] [Related]  

  • 2. International symposium on pertussis evaluation and research on acellular pertussis vaccines. National Institute of Health in Tokyo and International Association of Biological Standardization. 14-15 September 1990 at Shizuoka, Japan.
    Biologicals; 1991 Apr; 19(2):145-9. PubMed ID: 1888495
    [No Abstract]   [Full Text] [Related]  

  • 3. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acellular anti-pertussis vaccine].
    Bégué P; Grimpel E; Baron S
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):859-65. PubMed ID: 1819434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WHO guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines.
    Arciniega JL; Corbel M; Dellepiane N; Dobbelaer R; Griffiths E; Heron I; Ivanoff B; Kreeftenberg H; Mastrantonio P; Meade B; Milstein J; Robertson S; Robinson A; Sato H; Sato Y; Schwanig M; Tiru M
    Biologicals; 1998 Sep; 26(3):195-204. PubMed ID: 10208721
    [No Abstract]   [Full Text] [Related]  

  • 6. Pertussis component vaccine in Japan.
    Preston NW
    Lancet; 1984 Feb; 1(8374):456. PubMed ID: 6142187
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of acellular pertussis vaccine in Japan.
    Oda M; Higurashi M
    Acta Paediatr Jpn; 1988 Apr; 30(2):136-42. PubMed ID: 2907709
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens.
    Stevenson A; Roberts M
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):121-8. PubMed ID: 12832115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acellular pertussis vaccine].
    Wiedermann G; Ambrosch F; Vanura H
    Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
    Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Components of acellular pertussis vaccines.
    Preston NW; Matthews RC
    Lancet; 1996 Mar; 347(9003):764. PubMed ID: 8602023
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acellular pertussis vaccines].
    Finger H; Wirsing von König CH
    Immun Infekt; 1992 Dec; 20(6):188-91. PubMed ID: 1490723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines.
    Blaskett AC; Cox JC
    Epidemiol Infect; 1988 Jun; 100(3):335-44. PubMed ID: 2897927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pertactin in pertussis vaccines: the jury is still out.
    Desauziers E; Danve B; Decker MD; Veitch K
    J Infect Dis; 2004 Apr; 189(7):1332-3; author reply 1333-5. PubMed ID: 15031804
    [No Abstract]   [Full Text] [Related]  

  • 17. Acellular pertussis vaccines for infants.
    Edwards KM; Decker MD
    N Engl J Med; 1996 Feb; 334(6):391-2. PubMed ID: 8538712
    [No Abstract]   [Full Text] [Related]  

  • 18. Pertussis vaccines: present status.
    Christodoulides M
    Adv Biotechnol Processes; 1990; 13():169-99. PubMed ID: 2185783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
    Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME
    Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bordetella pertussis iron regulated proteins as potential vaccine components.
    Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
    Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.